|
[1]MENGHINI G.One-second needle biopsy of the liver[J].Gastroenterology, 1958, 35 (2) :190-199.
|
|
[2]SHIHA G, IBRAHIM A, HELMY A, et al.Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis:a 2016 update[J].Hepatol Int, 2017, 11 (1) :1-30.
|
|
[3]European Association for Study of Liver, Asociacion Latinoamericana para el Estudio del Hiqado.EASL-ALEH clinical practice guide lines:non-invasive tests for evaluation of liver disease severity and prognosis[J].J Hepatol, 2015, 63 (1) :237-264.
|
|
[4]JANG W, YU SI, SINN DH, et al.Longitudinal change of liver stiffness by transient elestography in chronic hepatitis B patients treated with nucleos (t) ide analogue[J].Clin Res Hepatol Gastroenterol, 2014, 38 (2) :195-200.
|
|
[5]DESMET VJ, GERBER M, HOOFNAGLE JH, et al.Classification of chronic hepatitis:diagnosis, grading and staging[J].Hepatology, 1994, 19 (6) :1513-1520.
|
|
[6]LEEVY C, TYGSTRUP N.Standardization of nomenclature, diagnostic criteria, and diagnostic methodology[M].Washington DC:Government Printing Office, 1976:9.
|
|
[7]LOEWI G.Mechanism of cell and tissue damage produced by immuno reactions:second international symposium on immunopathology, Michigan, U.S.A., 1961[J].Immunology, 1963, 6 (3) :301.
|
|
[8]POWELL LW.The nature of cell death in piecemeal necrosis:is order emerging from chaos?[J].Hepatology, 1987, 4 (7) :794-796.
|
|
[9]CZAJA AJ, CARPENTER HA.Histologic findings in chronic hepatitis C with autoimmune features[J].Hepatology, 1979, 26 (2) :459-466.
|
|
[10]FRENCH SW, ENBOM ET.Piecemeal necrosis of the liver revisited a review[J].Exp Mol Pathol, 2014, 96 (3) :307-309.
|
|
[11]MATTSSON L, WEILAND O, GLAUMANN H.Application of a numerical scoring system for assessment of histological outcome in patients with chronic post-transfusion non-A, non-B hepatitis with or without antibodies to hepatitis C[J].Liver, 1990, 10 (5) :257-263.
|
|
[12]YANO M, KUMADA H, KAGE M, et al.The long-term pathological evolution of chronic hepatitis C[J].Hepatology, 1996, 23 (6) :1334-1340.
|
|
[13]POYNARD T, BEDOSSA P, OPOLON P.Natural history of liver fibrosis progression in patients with chronic hepatitis C[J].Lancet, 1997, 349 (9055) :825-832.
|
|
[14]COOKSLEY WG, BRADBEAR RA, ROBINSON W, et al.The prognosis of chronic active hepatitis without cirrhosis in relation to bridging necrosis[J].Hepatology, 1986, 6 (3) :345-348.
|
|
[15]CHEN TJ, LIAW YF.The prognostic significance of bridging hepatic necrosis in chronic type B hepatitis:a histopathologic study[J].Liver, 1988, 8 (1) :10-16.
|
|
[16]KERR JF, COOKSLEY WG, SEARLE J, et al.The nature of piecemeal necrosis in chronic active hepatitis[J].Lancet, 1979, 20 (2) :827-828.
|
|
[17]de GROOTE J, DESMET VJ, GEDIGK P, et al.A classification of chronic hepatitis[J].Lancet, 1968, 2 (7568) :626-628.
|
|
[18]KNODELL RG, ISHAK KG, BLACK WC, et al.Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis[J].Hepatology, 1981, 1 (5) :431-435.
|
|
[19]SCHEUER PJ.Classification of chronic viral hepatitis:a need for reassessment[J].J Hepatol, 1991, 13 (3) :372-374.
|
|
[20]BATTS KP, LUDWIG J.Chronic hepatitis.An update on terminology and reporting[J].Am J Surg Pathol, 1995, 19 (12) :1409-1417.
|
|
[21]BEDOSSA P, POYNARD T.An algorithm for the grading of activity in chronic hepatitis C.The METAVIR Cooperative Study Group[J].Hepatology, 1996, 24 (2) :289-293.
|
|
[22]ISHAK K, BAPTISTA A, BIANCHI L, et al.Histological grading and staging of chronic hepatitis[J].J Hepatol, 1995, 22 (6) :696-699.
|
|
[23]SCHIFF ER, LEE SS, CHAO YC, et al.Long-term treatment with entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis B[J].Clin Gastroenterol Hepatol, 2011, 9 (3) :274-276.
|
|
[24]TRABER PG, CHOU H, ZOMER E, et al.Regression of fibrosis and reversal of cirrhosis in rats by galectin inhibitors in thioacetamide-induced liver disease[J].PLo S One, 2013, 8 (10) :e75361.
|
|
[25]LIAW YF.Reversal of cirrhosis:an achievable goal of hepatitis B antiviral therapy[J].J Hepatol, 2013, 59 (4) :880-881.
|
|
[26]KUTAMI R, GIRGRAH N, WANLESS IR, et al.The Laennec grading system for assessment of hepatic fibrosis:validation by correlation with wedged hepatic vein pressure and clinical features[J].Hepatology, 2000, 32 (4 Pt 2) :407A.
|
|
[27]BEDOSSA P.Reversibility of hepatitis B virus cirrhosis after therapy:who and why?[J].Liver Int, 2015, 35 (Suppl 1) :78-81.
|
|
[28]SUN Y, ZHOU J, WANG L, et al.New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment[J].Hepatology, 2017, 65 (5) :1438-1450.
|
|
[29]WANLESS IR, NAKASHIMA E, SHERMAN M.Regression of human cirrhosis.Morphologic features and the genesis of incomplete septal cirrhosis[J].J Arch Pathol Lab Med, 2000, 124 (11) :1599-1607.
|
|
[30]SETHASINE S, JAIN D, GROSZMANN RJ, et al.Quantitative histological-hemodynamic correlations in cirrhosis[J].Hepatology, 2012, 55 (4) :1146-1153.
|
|
[31]WANG Y, HOU JL.Fibrosis assessment:impact on current management of chronic liver disease and application of quantitative invasive tools[J].Hepatol Int, 2016, 10 (3) :448-461.
|
|
[32]XU S, WANG Y, TAI DC, et al.q Fibrosis:a fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients[J].J Hepatol, 2014, 61 (2) :260-269.
|
|
[33]ASSELAH T, MARCELLIN P, BEDOSSA P.Improving performance of liver biopsy in fibrosis assessment[J].J Hepatol, 2014, 61 (2) :193-195.
|
|
[34]STRUPLER M, PENA AM, HERNEST M, et al.Second harmonic imaging and scoring of collagen in fibrotic tissues[J].J Opt Express, 2007, 15 (7) :4054-4065.
|
|
[35]ROUSSELET MC, MICHALAK S, DUPRE F, et al.Sources of variability in histological scoring of chronic viral hepatitis[J].Hepatology, 2005, 41 (2) :257-264.
|
DownLoad: